AT1 FY21 - General Discussion + FA, page-25

Its a good question. My view is the same, low to cruising for July-Sept total. Increasing Covid19 $ Oct-Dec2020, then hitting its stride from Jan21 onwards. Hard to quantify $ though without more orders/regular runrate still to be established. Below is my thinking:

As we discussed earlier, we should see a fairly regular stream of updates as various goals reach end. But these won't necessarily = revenue $ for this Qtr or start of next Qtr.

If NGBio had ordered remainder 700k+, it would be announced, as its significant enough ($5m+ being last annual = pretty low material cap for order that can shift annual total).

I am expecting NGBio to take up remainder in 2020, but it could arrive in Oct-Dec2020, so in next Qtr total.

Yes, all the Covid19 initiatives are building steam, so my expectations for increasing revenue is from end Nov20 to a stronger/regular flow from Jan21 onwards. Oct-Dec 2020, US FDA approval for Ab tests should be thru, so reasonably, I expect a US order (roughly should be 500k+/mth spare capacity from Sept, looking at FY20 non-Covid19 total vs current 750k/mth prouction rate)...so Oct-Dec, there should be a lovely 1-1.5m qty shipping out or ready to bulk ship for Q1 2021 (even after fulfilling NGBio 700k+ remainder).

India approval could come thru Nov-Dec 2020 or worst case early Jan2021...so resonably the first 77k order in Dec2020 or Jan2021..after that, it could take off in large bulk orders or keep a steady run rate per mth as Divoc scales up its side.

Anything antigen is total bonus for us, extra gravy on the side, might be lumpy per qtr for now.

HIV not expecting anything dramatic for this qtr or next 2 qtrs. Worlds attention + $ is still focussed on Covid19. Mylan has to finish merger...so I am looking at HIV increasing by mid 2021...regular trend till then.

FebriDx is an unknown qty, since we don't know what the needs are/would be, whats the timeline for Lumos scale-up of their test strip and if AT1 will supply direct or licence out device. On balance, I put FebriDX revenue to show increasing movement/some trend in Jan-Mar 2021...bonus if anything significant ordered by end 2020.